Standout Papers

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL... 2008 2026 2014 2020 572
  1. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease (2008)
    Norihiro Nishimoto, Kimio Terao et al. Blood

Immediate Impact

9 from Science/Nature 89 standout
Sub-graph 1 of 20

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
2 intermediate papers

Works of Hideko Nakahara being referenced

A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment
2011
Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
2008 Standout

Author Peers

Author Last Decade Papers Cites
Hideko Nakahara 471 282 326 20 1.2k
Lucy Rowell 465 199 223 31 1.1k
Shubhasree Banerjee 371 133 346 23 1.2k
Nobuhiro Takagi 732 383 529 21 1.6k
Apostolos Kontzias 301 363 400 31 1.3k
Marcel D. Posthumus 656 211 338 30 1.4k
Ulf Müeller-Ladner 610 157 211 27 1.2k
J. Sydney Stillman 464 598 351 23 1.4k
Pierre‐Yves Berclaz 370 182 621 30 1.6k
Karin Manger 725 141 523 30 1.2k
Daniel B. Magilavy 436 286 506 36 1.4k

All Works

Loading papers...

Rankless by CCL
2026